Renalyx Health Systems

What Renalyx Health Systems does

Renalyx Health Systems Private Limited, founded in October 2012 in Bengaluru, India, is a medical device company developing indigenous hemodialysis and renal care technology. The company serves healthcare providers, hospitals, dialysis centers, primary care facilities, and nephrologists with an end-to-end renal care platform spanning early Chronic Kidney Disease (CKD) detection through acute and chronic dialysis treatment. Its product portfolio comprises the RxT21, an AI-based smart hemodialysis machine designed for Sustained Low Efficiency Dialysis (SLED) in ICU settings; the RxT17 PHC Dialysis Machine for primary healthcare ESRD treatment; ReachnCare, a point-of-care early CKD detection system using patented microalbumin/creatinine strips with cloud-based EMR generation; and a cloud-based Digital Nephrology Platform that automates dialysis workflows, reporting, and remote patient monitoring. The company holds CE marking, CDSCO Class C manufacturing licenses (held by both BEL and Lords Mark Industries), ISO 13485 certification, and DSIR R&D recognition.

The company generates revenue through three streams: medical device hardware sales (dialysis machines and diagnostic devices), recurring software/subscription services via the Digital Nephrology Platform, and consumables (dialysers and supplies). Distribution follows a hybrid OEM and channel model: Bharat Electronics Limited (BEL), a defense PSU, manufactures the RxT17 under license; Genworks handles pan-India distribution and servicing; Vinyas Innovative Technologies provides manufacturing services from Mysore; and Browndove supplies consumables. Pricing is quote-based for enterprise healthcare providers and is not publicly disclosed. Clinical validation has been conducted at hospitals including Narayana Hrudayalaya, St. John's Medical College, and Apollo Hospital Chennai. The company has been majority-owned (85%) by Lords Mark Industries since November 2025, operating as part of the Lord's Mark Group, with a Rs. 800 crore capital plan to establish 3 production units in Karnataka over 4 years.

Name

Renalyx Health Systems

Legal name

Renalyx Health Systems Private Limited

Website

https://renalyx.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Renalyx Health Systems is a Bengaluru-based medical device company developing indigenous AI-enabled hemodialysis machines, point-of-care CKD diagnostic devices, and a cloud-based Digital Nephrology Platform serving hospitals, dialysis centers, and primary healthcare providers in India.

Ownership category

akta.pro rank

Product category

Hemodialysis Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodialysis Machines & Systems (HLAHAKAA)

akta.pro secondary industries

Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ), Nephrology Telemedicine Platforms (HLALAGAI), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)

Keywords

• Hemodialysis machines
• Renal care solutions
• Chronic kidney disease
• Dialysis equipment
• Medical device manufacturing

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of hemodialysis machines (RxT17 and RxT21), point-of-care diagnostic devices, and related medical equipment to healthcare providers and hospitals.
2. Software/Subscription Services: Digital Nephrology Platform providing cloud-based dialysis workflow automation, remote monitoring, and analytics services.
3. Consumables: Dialysis consumables including dialysers and other supplies used during hemodialysis sessions through partnership with Browndove.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Renalyx Health Systems designs, develops and manufactures indigenous hemodialysis machines (RxT17 and RxT21) along with a cloud-based Digital Nephrology Platform and the ReachnCare point-of-care CKD early detection system. The company provides an end-to-end renal care solution spanning early Chronic Kidney Disease detection, dialysis treatment for ESRD and ICU patients, and remote patient monitoring by qualified nephrologists.

Product overview

Renalyx Health Systems offers a comprehensive end-to-end renal care solution comprising four integrated products. The portfolio centers on the RxT21, the world's first indigenous AI-based SLED (Sustained Low Efficiency Dialysis) hemodialysis machine for ICU renal replacement therapy, complemented by the RxT17 PHC Dialysis Machine for primary healthcare ESRD treatment. The ReachnCare system provides early CKD detection using patented test strips with ACR analysis and a companion mobile app for disease management. All dialysis machines connect through the Digital Nephrology Platform, a cloud-based system that automates workflows, enables remote patient monitoring by nephrologists, and tracks operational metrics. The company operates as part of Lord's Mark Group following an 85% stake acquisition.

Differentiator

Problem solved

Functional benefit

Products and services

• RxT21 AI-Based Smart Hemodialysis Machine AI-powered Sustained Low Efficiency Dialysis (SLED) hemodialysis machine designed for renal replacement therapy in intensive care unit settings. Features AI-based monitoring, clinical connectivity, and remote vital statistics monitoring by qualified nephrologists, and is positioned for hospital ICUs and tertiary care centers treating patients with acute renal failure.
• RxT17 PHC Dialysis Machine Indigenously developed Primary Healthcare (PHC) hemodialysis machine for treating CKD stage-5 (ESRD) patients, with CE certification, color touchscreen display, audio-visual alarms and remote vital statistics monitoring by qualified nephrologists.
• ReachnCare CKD Early Detection System Point-of-care early CKD detection system combining patented Microalbumin and Creatinine test strips that produce an ACR reading with a mobile app that functions as a virtual assistant for stages 1-4 disease management, supports GP workflows, manages diabetes and hypertension, and generates cloud-based EMRs for primary care and rural use.
• Digital Nephrology Platform Cloud-based web system that automates dialysis workflows, auditing and reporting, and enables remote monitoring of dialysis machines and tracking of key metrics such as machine utilization, maintenance, staffing and consumables for healthcare providers operating dialysis units.

Quantifiable outcome

• Addressed rising demand for dialysis care driven by increasing End-Stage Renal Disease cases in India
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Bharat Electronics Limited (BEL)coreOEM/ Whitelabel/ Licensing PartnerRenalyx is associated with Bharat Electronics for the manufacturing of RxT17 Hemodialysis machine. BEL obtained CDSCO license to manufacture the device. Renalyx is also joint technology partner for collaborative R&D.
• IIT KharagpurcoreStrategic or Co-development PartnerRenalyx is associated with Department of Chemical Engineering and School of Medical Science and Technology for R&D in dialysis membrane. Jointly won Technology Innovation award for dialyser development.
• Vinyas Innovative TechnologiescoreTechnology or IntegrationRenalyx is associated with Vinyas Innovative Technologies for manufacturing services of medical products in their state-of-the-art facility located at Mysore.
• Genworks HealthcoreChannel Partner/ Reseller/ DistributorRenalyx is associated with Genworks for distribution, sales and servicing of Renalyx products across India.
• PESIT (PES College of Engineering)minorStrategic or Co-development PartnerRenalyx is associated with PESIT Center of Research and Innovation for R&D in dialysis for rural CKD patients.
• BMSIT (BMS College of Engineering)minorStrategic or Co-development PartnerRenalyx is associated with Innovation Center of Department of Medical Electronics for research in Point of Care devices for detection of early stage CKD.
• eHealth EnablersminorStrategic or Co-development PartnerRenalyx is associated with eHealth Enablers, one of the first accelerators for Healthcare enabling startup companies.
• Swasthya Med-CminorOthersRenalyx is associated with Swasthya Med-C, an association of Medical Electronics Devices Manufacturers with over 30 members forming a cluster ecosystem for medical electronics devices companies and startups.

Scale indicators4 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• DaVita: One of the two largest dialysis service providers globally, operating thousands of outpatient dialysis centres. Overlaps with Renalyx on the demand side — DaVita-style providers are potential large-volume buyers of Renalyx's machines and platform.
• Fresenius Medical Care: Global leader in dialysis products and services, manufacturing hemodialysis machines, dialyzers and consumables while also operating the largest dialysis clinic network. Directly comparable to Renalyx on the hemodialysis hardware side and represents the dominant incumbent Renalyx must displace.
• B. Braun Avitum: Division of B. Braun that develops and supplies hemodialysis machines (Dialog+, Omni), dialyzers and therapy solutions globally. Directly comparable product portfolio to Renalyx's RxT17/RxT21 across hospital and clinic segments.
• Asahi Kasei Medical: Leading global supplier of dialysis membranes (dialyzers) and other renal-care consumables. Comparable to Renalyx on the renal consumables/materials side and represents a potential partnership or competitive overlap.
• Nipro Corporation: Japanese medical device company with a substantial renal care business producing dialyzers, hemodialysis machines and dialysis-related disposables. Comparable to Renalyx as a vertically integrated dialysis products competitor, particularly in Asia.
• Baxter International (Vantive / Kidney Care): Long-established dialysis products business (now being separated as Vantive) selling hemodialysis machines, PD systems and dialyzers globally. Renalyx advisor Dr. Prakash Keshaviah is a former Baxter VP R&D, underscoring direct technology overlap.

Regional players

• BPL Medical Technologies: Indian medical device company with a broad portfolio including patient monitoring and related equipment. Comparable as an India-based medical device manufacturer pursuing domestic and emerging-market hospital customers with indigenous products.
• Trivitron Healthcare: India-headquartered medical technology company offering a wide range of medical devices and diagnostic solutions across emerging markets. Comparable as an Indian medtech peer building indigenous products for hospital and diagnostic segments.

Emerging players

• Quanta Dialysis Technologies: UK-based company commercialising a compact, easy-to-use hemodialysis system (SC+) aimed at expanding dialysis into more care settings. Comparable to Renalyx as a technology-focused challenger aiming to broaden dialysis access beyond traditional centres.
• Outset Medical: US-based developer of the Tablo Hemodialysis System — an enterprise-grade connected hemodialysis platform designed for clinic and hospital use with cloud connectivity. Most directly comparable tech/digital-native peer to Renalyx's RxT21 + Digital Nephrology Platform vision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/FortuneIndia/status/1933516140006769044
• LinkedInlinkedin.com/posts/digitalhealthnews_renalyx-rxt21-dialysisinnovation-activity-7338836428375629826-tCpH?utm_source=share&utm_medium=member_desktop&rcm=ACoAACxyA0QBfstADpkCEWkjfqsM7dk3Il4JMJc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renalyx Health Systems